Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-06-10 to 2025-06-11
Current total value of award: $3379.2
Description: 4568513858!QUILLIVANT XR 25 MG/5 ML SUSP 120ML